Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Feature
CAR T-cell therapy turns 10 and finally earns the word ‘cure’
Publish date:
July 22, 2022
A version of this article first appeared on
Medscape.com
.
Pages
« first
1
2
3
4
Recommended Reading
Eating olive oil may slow CLL disease progression
MDedge Hematology and Oncology
First-line CAR T-cell therapy could help cure some lymphomas
MDedge Hematology and Oncology
Some leukemias detectable up to 16 years before diagnosis?
MDedge Hematology and Oncology
Rapper sings about living with sickle cell disease
MDedge Hematology and Oncology
Novel COVID-19 vaccine could fill the void for patients with blood cancers
MDedge Hematology and Oncology
Cancer patients unaware of their increased thrombosis risk
MDedge Hematology and Oncology
Updated AHA/ASA guideline changes care for spontaneous intracerebral hemorrhage
MDedge Hematology and Oncology
Patients with blood cancers underutilize palliative care
MDedge Hematology and Oncology
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
MDedge Hematology and Oncology
FDA warning: Lymphoma drug heightens risk of death
MDedge Hematology and Oncology
ALL
CLL
Cellular Therapy
All Specialties
